Hanna NH - Search Results

1

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.

Albany C, Fazal Z, Singh R, Bikorimana E, Adra N, Hanna NH, Einhorn LH, Perkins SM, Sandusky GE, Christensen BC, Keer H, Fang F, Nephew KP, Spinella MJ. Albany C, et al. Among authors: hanna nh. Cancer Med. 2021 Jan;10(1):156-163. doi: 10.1002/cam4.3583. Epub 2020 Nov 1. Cancer Med. 2021. PMID: 33135391 Free PMC article. Clinical Trial.

2

Diagnostic and therapeutic quandaries in a patient with a germ cell tumor.

Hanna N, Kesler K, Einhorn L. Hanna N, et al. J Clin Oncol. 2001 Oct 15;19(20):4088. doi: 10.1200/JCO.2001.19.20.4088. J Clin Oncol. 2001. PMID: 11600612 No abstract available.

3

Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.

Hanna NH, Sandier AB, Loehrer PJ Sr, Ansari R, Jung SH, Lane K, Einhorn LH. Hanna NH, et al. Ann Oncol. 2002 Jan;13(1):95-102. doi: 10.1093/annonc/mdf014. Ann Oncol. 2002. PMID: 11863118 Free article. Clinical Trial.

4

Primary choriocarcinoma of the bladder with the detection of isochromosome 12p.

Hanna NH, Ulbright TM, Einhorn LH. Hanna NH, et al. J Urol. 2002 Apr;167(4):1781. J Urol. 2002. PMID: 11912411 No abstract available.

5

Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies.

Hanna NH, Gordon MS, Fife K, Sandler AB. Hanna NH, et al. Am J Clin Oncol. 2002 Aug;25(4):337-9. doi: 10.1097/00000421-200208000-00002. Am J Clin Oncol. 2002. PMID: 12151959 Clinical Trial.

6

The value of platinum compounds in non-small-cell lung cancer.

Hanna NH, Einhorn LH. Hanna NH, et al. Clin Lung Cancer. 2002 May;3(4):249-53. doi: 10.3816/clc.2002.n.008. Clin Lung Cancer. 2002. PMID: 14662032

7

Second-line chemotherapy for non-small-cell lung cancer: recent data with pemetrexed.

Hanna NH. Hanna NH. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S75-9. doi: 10.3816/clc.2004.s.007. Clin Lung Cancer. 2004. PMID: 15117429 Review.

8

Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment.

Shafqat A, Einhorn LH, Hanna N, Sledge GW, Hanna A, Juliar BE, Monahan P, Bhatia S. Shafqat A, et al. Ann Oncol. 2005 Sep;16(9):1545-50. doi: 10.1093/annonc/mdi267. Epub 2005 May 26. Ann Oncol. 2005. PMID: 15919683 Free article.

9

Long-term survival in a patient with stage IV non-small-cell lung carcinoma after bone metastasectomy.

Agarwala AK, Hanna NH. Agarwala AK, et al. Among authors: hanna nh. Clin Lung Cancer. 2005 May;6(6):367-8. doi: 10.3816/CLC.2005.n.017. Clin Lung Cancer. 2005. PMID: 15943898

10

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University.

Kurup A, Lin C-, Murry DJ, Dobrolecki L, Estes D, Yiannoutsos CT, Mariano L, Sidor C, Hickey R, Hanna N. Kurup A, et al. Ann Oncol. 2006 Jan;17(1):97-103. doi: 10.1093/annonc/mdj055. Epub 2005 Nov 9. Ann Oncol. 2006. PMID: 16282244 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters